- 24/7 Wall St.•5 hours ago
These are some of the biggest biopharma stocks moving on Wednesday, as markets have hit new intraday highs, continuing to climb in the wake of the White House announcements.
- TheStreet.com•8 hours ago
Absent specific policy details, Trump's speech leaves investors guessing about his real plans for the FDA and the drug approval process. He has not yet named an FDA commissioner.
- GlobeNewswire•9 hours ago
Growing Momentum for EU Galafold Launch for Fabry Disease Tracking Toward 300 Patients by Year-End 2017. Target Enrollment Achieved in Phase 1/ 2 Pompe Study– Additional Data Expected in 2 Q17 and 3 Q17. ...
FOLD : Summary for Amicus Therapeutics, Inc. - Yahoo Finance
Amicus Therapeutics, Inc. (FOLD)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||7.58 x 500|
|Ask||7.60 x 100|
|Day's Range||6.83 - 7.79|
|52 Week Range||4.41 - 9.83|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-5.36|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|